Intelligence · Clinical Pipeline
Bristol-Myers Squibb Australia Pipeline
All ClinicalTrials.gov programs at Bristol-Myers Squibb Australia — phase, modality, and trial IDs.
- Programs
- 51
Quick answer
Bristol-Myers Squibb Australia has 51 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
deucravacitinib, Placebo to match deucravacitinib 6mg tablets in bottle, oral use, deucravacitinib, Placebo to match deucravacitinib 2mg minitablets in sachet, oral use
Bristol-Myers Squibb Australia Pty Ltd
Moderate to Severe Plaque Psoriasis
1 trial -
deucravacitinib, Placebo to match deucravacitinib tablet
Bristol-Myers Squibb Australia Pty Ltd
Active Psoriatic Arthritis
1 trial -
deucravacitinib, deucravacitinib, Deucravacitinib placebo 2mg film-coated tablets in sachet, oral use, deucravacitinib
Bristol-Myers Squibb Australia Pty Ltd
Juvenile Psoriatic Arthritis (JPsA)
1 trial
Frequently asked questions
How many pipeline programs does Bristol-Myers Squibb Australia have?
51 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs